{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:53:40Z","timestamp":1788576820536,"version":"build-2803163510"},"reference-count":97,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[1992,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>The purpose of this article is to review the pathophysiology of the denervated heart and the factors that need to be considered before recommending the use of over-the-counter (OTC) medications in the cardiac transplant recipient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>Pharmacology and therapeutic textbooks, English-language journal articles, and physiology textbooks published between 1969 and 1991.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Case reports, controlled case studies, and textbook chapters evaluating drug interactions with immunosuppressive agents were reviewed. The effects of various OTC medications on the denervated heart were examined and relevant material was extrapolated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA ANALYSIS:<\/jats:title>\n                    <jats:p>The number of cases or studies in which a particular effect or interaction occurred was reported. Those findings that were less well documented were either identified as such or were not included in the review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>Common pharmacokinetic and pharmacodynamic interactions with the primary immunosuppressive agents (e.g., cyclosporine, azathioprine, prednisone) are reviewed. The physiology and altered responses of the denervated heart to various medications are also explained. Using this information, recommendations are given for the use and monitoring of OTC analgesics, antacids, laxatives, sleep aids, stimulants, and other medications that may be used in the cardiac transplant recipient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Many OTC medications can be used safely in the cardiac transplant recipient. In each situation, risk\/benefit assessments must always be made and therapy should be monitored closely. Most important, patients should always notify the transplant team before adding an OTC product to their immunosuppressive regimen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/106002809202601216","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T15:24:47Z","timestamp":1484321087000},"page":"1566-1575","source":"Crossref","is-referenced-by-count":10,"title":["Over-the-Counter Medications in Cardiac Transplant Recipients: Guidelines for Use"],"prefix":"10.1177","volume":"26","author":[{"given":"Kathleen D.","family":"Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline G.","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Slaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Reutzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry K.","family":"Milfred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane F.","family":"Solbrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[1992,12]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"25","volume-title":"Handbook of nonprescription drugs","author":"Gilbertson WE","year":"1990","unstructured":"Gilbertson WE. The FDA's OTC drug review. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 25\u201340.","edition":"9"},{"issue":"16","key":"e_1_2_1_3_2","first-page":"1","article-title":"Jumping over the counter: Rx to OTC switch","volume":"1","author":"Sullivan AM","year":"1990","unstructured":"Sullivan AM. Jumping over the counter: Rx to OTC switch. Pharm Update 1990; 1 (16):1\u201313.","journal-title":"Pharm Update"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0160-3450(16)33681-9"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198510000-00025"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198402000-00020"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198303000-00005"},{"key":"e_1_2_1_8_2","first-page":"213","article-title":"Enhancement of cyclosporine A nephrotoxicity by diclofenac","volume":"27","author":"Deray G","year":"1987","unstructured":"Deray G, Le Hoang P, Aupetit B, Achour A, Rottembourg J, Baumelou A. Enhancement of cyclosporine A nephrotoxicity by diclofenac. Clin Nephrol 1987; 27: 213\u20134.","journal-title":"Clin Nephrol"},{"key":"e_1_2_1_9_2","first-page":"56","article-title":"Drug interactions with cyclosporine: Implications from animal studies","volume":"18","author":"Whiting PH","year":"1986","unstructured":"Whiting PH, Burke MD, Thomson AW. Drug interactions with cyclosporine: Implications from animal studies. Transplant Proc 1986; 18 (suppl):56\u201370.","journal-title":"Transplant Proc"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1991.tb02640.x"},{"issue":"4","key":"e_1_2_1_11_2","first-page":"617","article-title":"Cyclosporine drug interactions: A review","volume":"2","author":"Lake KD","year":"1988","unstructured":"Lake KD. Cyclosporine drug interactions: A review. Cardiac Surg: State Art Rev 1988; 2 (4):617\u201330.","journal-title":"Cardiac Surg: State Art Rev"},{"key":"e_1_2_1_12_2","first-page":"1203","article-title":"Pharmacokinetic interactions between cyclosporine and other drugs","volume":"22","author":"Yee GC","year":"1990","unstructured":"Yee GC. Pharmacokinetic interactions between cyclosporine and other drugs. Transplant Proc 1990; 22: 1203\u20137.","journal-title":"Transplant Proc"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199019040-00004"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199019050-00004"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(89)90541-2"},{"key":"e_1_2_1_16_2","first-page":"3845","article-title":"An appraisal of drug interactions with Sandimmune","volume":"21","author":"Cockburn IT","year":"1989","unstructured":"Cockburn IT, Krupp P. An appraisal of drug interactions with Sandimmune. Transplant Proc 1989; 21: 3845\u201350.","journal-title":"Transplant Proc"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018030-00004"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70358-O"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.87"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)08600-3"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00195.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197612000-00003"},{"key":"e_1_2_1_23_2","first-page":"767","article-title":"Immunosuppressive therapy and anesthesia","volume":"47","author":"Vetten KB","year":"1973","unstructured":"Vetten KB. Immunosuppressive therapy and anesthesia. S Afr Med J 1973; 47: 767\u201370.","journal-title":"S Afr Med J"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270180034016"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197918020-00003"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-38-3-407"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197711000-00018"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6369.923"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)80745-7"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-5238-2_15"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)37294-0"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(19)42581-6"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.45.6.1183"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.40.4.437"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(75)90074-0"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.5.914"},{"key":"e_1_2_1_37_2","first-page":"266","volume-title":"Heart and heart-lung transplantation","author":"Traill TA","year":"1990","unstructured":"Traill TA. Physiology and function of the transplant allograft. In: Baumgartner WA, Reitz BA, Achuff SC, eds. Heart and heart-lung transplantation. Philadelphia: WB Saunders, 1990: 266\u201378."},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.4.888"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.67.1.38"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108663"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.153"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198836010-00006"},{"key":"e_1_2_1_43_2","volume-title":"Drug interactions","author":"Hansten PD","year":"1989","unstructured":"Hansten PD, Horn JR. In: Drug interactions. 6th ed. Lea & Febiger, 1989.","edition":"6"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198609000-00018"},{"key":"e_1_2_1_45_2","first-page":"569","article-title":"Inhibition of cyclosporin metabolism by other drugs in vitro","volume":"20","author":"Hendricksson S","year":"1988","unstructured":"Hendricksson S, Lindholm A. Inhibition of cyclosporin metabolism by other drugs in vitro. Transplant Proc 1988; 20: 569\u201371.","journal-title":"Transplant Proc"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.281.6243.775"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)06902-8"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198908000-00038"},{"key":"e_1_2_1_49_2","first-page":"401","article-title":"Ranitidine does not influence cyclosporine levels in renal transplant patients (abstract)","volume":"28","author":"Zazgornik J","year":"1985","unstructured":"Zazgornik J, Schindler J, Gremmel F, Bakke P, Kopsa H, Derfler K, . Ranitidine does not influence cyclosporine levels in renal transplant patients (abstract). Kidney Int 1985; 28: 401.","journal-title":"Kidney Int"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528709090142"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/6.4.552"},{"key":"e_1_2_1_52_2","first-page":"351","article-title":"Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation","volume":"10","author":"Butman SM","year":"1991","unstructured":"Butman SM, Wild JC, Nolan PE, Fagan TC, Finley PR, Hicks MJ, . Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 1991; 10: 351\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_1_53_2","first-page":"383","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Baldessarini RJ","year":"1990","unstructured":"Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Goodman AG, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 383\u2013435.","edition":"8"},{"key":"e_1_2_1_54_2","first-page":"187","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Hoffman BB","year":"1990","unstructured":"Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 187\u2013220.","edition":"8"},{"key":"e_1_2_1_55_2","first-page":"133","volume-title":"Handbook of nonprescription drugs","author":"Bryant BG","year":"1990","unstructured":"Bryant BG, Lombardi TP. Cold and allergy products. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 133\u2013205.","edition":"9"},{"key":"e_1_2_1_56_2","first-page":"575","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Garrison JC","year":"1990","unstructured":"Garrison JC. Histamine, bradykinin, and 5- hydroxytryptamine, and their antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 575\u201399.","edition":"8"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb03950.x"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510060-00002"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90164-9"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)07677-9"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450210088038"},{"key":"e_1_2_1_62_2","first-page":"485","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Jaffe JH","year":"1990","unstructured":"Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 485\u2013521.","edition":"8"},{"key":"e_1_2_1_63_2","first-page":"57","volume-title":"Handbook of nonprescription drugs","author":"Van Tyle WK","year":"1990","unstructured":"Van Tyle WK. Internal analgestic products. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 57\u201389.","edition":"9"},{"key":"e_1_2_1_64_2","first-page":"638","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Insel PA","year":"1990","unstructured":"Insel PA. Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 638\u201381.","edition":"8"},{"key":"e_1_2_1_65_2","first-page":"1264","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Handschumacher RE","year":"1990","unstructured":"Handschumacher RE. Immunosuppressive agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 1264\u201376.","edition":"8"},{"key":"e_1_2_1_66_2","first-page":"1431","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Haynes RC","year":"1990","unstructured":"Haynes RCJr. Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 1431\u201362.","edition":"8"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808902300122"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03330210046033"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.144"},{"key":"e_1_2_1_70_2","first-page":"445","article-title":"Sulindac-induced elevation of serum cyclosporine concentration","volume":"8","author":"Sesin GP","year":"1989","unstructured":"Sesin GP, O'Keefe E, Roberto P. Sulindac-induced elevation of serum cyclosporine concentration. Clin Pharm 1989; 8: 445\u20136.","journal-title":"Clin Pharm"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90223-2"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197612022952306"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905113201903"},{"key":"e_1_2_1_74_2","first-page":"897","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Brunton LL","year":"1990","unstructured":"Brunton LL. Agents for control of gastric acidity and treatment of peptic ulcers. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 897\u2013913.","edition":"8"},{"key":"e_1_2_1_75_2","first-page":"2438","article-title":"The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay","volume":"15","author":"Keown PA","year":"1983","unstructured":"Keown PA, Stiller CR, Sinclair NR, Howson W, Stawecki M, McMichael J, . The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay. Transplant Proc 1983; 15: 2438\u201341.","journal-title":"Transplant Proc"},{"key":"e_1_2_1_76_2","first-page":"27","article-title":"The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients","volume":"20","author":"Keogh A","year":"1988","unstructured":"Keogh A, Day R, Critchley L, Duggin G, Baron D. The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients. Transplant Proc 1988; 20: 27\u201330.","journal-title":"Transplant Proc"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198508000-00013"},{"key":"e_1_2_1_78_2","first-page":"148","article-title":"Food increases the bioavailability of cyclosporine in healthy volunteers (abstract)","volume":"45","author":"Gupta SK","year":"1989","unstructured":"Gupta SK, Benet LZ. Food increases the bioavailability of cyclosporine in healthy volunteers (abstract). Clin Pharmacol Ther 1989; 45: 148.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_79_2","first-page":"243","volume-title":"Handbook of nonprescription drugs","author":"Garnett WR","year":"1990","unstructured":"Garnett WR. Antacid products. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 243\u201392.","edition":"9"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90122-0"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00952.x"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb05919.x"},{"key":"e_1_2_1_83_2","first-page":"167","article-title":"Immunosuppressive treatment policies: A) absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids","volume":"64","author":"Bergrem H","year":"1981","unstructured":"Bergrem H, Djoseland O, Jervell J, Rugstad HE. Immunosuppressive treatment policies: A) absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids. Scand J Urol Nephrol 1981; 64 (suppl):167\u201373.","journal-title":"Scand J Urol Nephrol"},{"key":"e_1_2_1_84_2","volume-title":"The 1988 report of the Joint National Commission on Detection, Evaluation, and Treatment of High Blood Pressure","author":"US Department of Health and Human Services.","unstructured":"US Department of Health and Human Services. The 1988 report of the Joint National Commission on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: Department of Health and Human Services, May 1988, 3, 12, 20; NIH publication no. 88\u20131088."},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1991.11700928"},{"key":"e_1_2_1_86_2","first-page":"313","volume-title":"Handbook of nonprescription drugs","author":"Longe RL","year":"1990","unstructured":"Longe RL. Antidiarrheal and other gastrointestinal products. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 313\u201331.","edition":"9"},{"key":"e_1_2_1_87_2","first-page":"914","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Brunton LL","year":"1990","unstructured":"Brunton LL. Agents affecting gastrointestinal water flux and motility, digestants, and bile acids. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 914\u201332.","edition":"8"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270080026025"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197611042951902"},{"key":"e_1_2_1_90_2","first-page":"38","article-title":"Pharmacokinetics. 1. Definitions, modeling and reasons for measuring blood levels and urinary excretion","volume":"2","author":"Wagner JG","year":"1968","unstructured":"Wagner JG. Pharmacokinetics. 1. Definitions, modeling and reasons for measuring blood levels and urinary excretion. Drug Intell Clin Pharm 1968; 2: 38\u201342.","journal-title":"Drug Intell Clin Pharm"},{"key":"e_1_2_1_91_2","first-page":"343","volume-title":"Handbook of nonprescription drugs","author":"Curry CE","year":"1990","unstructured":"Curry CE, Tatum-Butler D. Laxative products. In: Feldman EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 343\u201364.","edition":"9"},{"key":"e_1_2_1_92_2","first-page":"610A","article-title":"Altered bioavailability of digoxin produced by gastrointestinal medications (abstract)","volume":"27","author":"Brown DD","year":"1979","unstructured":"Brown DD, Juhl RP. Altered bioavailability of digoxin produced by gastrointestinal medications (abstract). Clin Res 1979; 27: 610A.","journal-title":"Clin Res"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600640621"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-3-290"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03180170077028"},{"key":"e_1_2_1_96_2","first-page":"293","volume-title":"Handbook of nonprescription drugs","author":"Odera GM","year":"1990","unstructured":"Odera GM, Korberly BH. Emetic and antiemetic products. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 293\u2013312.","edition":"9"},{"key":"e_1_2_1_97_2","first-page":"22641","volume-title":"Handbook of nonprescription drugs","author":"Caro JP","year":"1990","unstructured":"Caro JP, Dombrowski SR. Sleep aid products. In: Feldmann EG, Blockstein WL, Young LL, McGinnis JV, Meade VL, Lawson LC, eds. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Association, 1990: 22641.","edition":"9"},{"key":"e_1_2_1_98_2","first-page":"618","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Rail TW","year":"1990","unstructured":"Rail TW. Drugs used in the treatment of asthma: The methylxanthines, cromolyn sodium, and other agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 618\u201337.","edition":"8"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809202601216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809202601216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:05:03Z","timestamp":1777374303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809202601216"}},"subtitle":[],"editor":[{"given":"Edward A.","family":"Hartshorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["10.1177\/106002809202601216"],"URL":"https:\/\/doi.org\/10.1177\/106002809202601216","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]}}}